{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T19:27:42Z","timestamp":1781983662386,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81470240"],"award-info":[{"award-number":["81470240"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017949","name":"Health Commission of Shanxi Province","doi-asserted-by":"publisher","award":["201601010"],"award-info":[{"award-number":["201601010"]}],"id":[{"id":"10.13039\/100017949","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Doctoral Foundation of Shanxi Bethune Hospital","award":["2019YJ01"],"award-info":[{"award-number":["2019YJ01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s12010-023-04671-y","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T10:02:52Z","timestamp":1693562572000},"page":"3374-3386","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Baicalin Relieves Airway Inflammation in COPD by Inhibiting miR-125a"],"prefix":"10.1007","volume":"196","author":[{"given":"Xia","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Huo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianying","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,1]]},"reference":[{"key":"4671_CR1","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.2147\/COPD.S176122","volume":"13","author":"Y Wang","year":"2018","unstructured":"Wang, Y., et al. (2018). Role of inflammatory cells in airway remodeling in COPD. International journal of chronic obstructive pulmonary disease, 13, 3341.","journal-title":"International journal of chronic obstructive pulmonary disease"},{"key":"4671_CR2","doi-asserted-by":"publisher","first-page":"591","DOI":"10.2147\/COPD.S153694","volume":"13","author":"LP de Llano","year":"2018","unstructured":"de Llano, L. P., et al. (2018). Mixed Th2 and non-Th2 inflammatory pattern in the asthma\u2013COPD overlap: A network approach. International journal of chronic obstructive pulmonary disease, 13, 591.","journal-title":"International journal of chronic obstructive pulmonary disease"},{"issue":"5","key":"4671_CR3","doi-asserted-by":"publisher","first-page":"609","DOI":"10.4187\/respcare.05943","volume":"63","author":"AW Huckle","year":"2018","unstructured":"Huckle, A. W., Fairclough, L. C., & Todd, I. (2018). Prophylactic antibiotic use in COPD and the potential anti-inflammatory activities of antibiotics. Respiratory care, 63(5), 609\u2013619.","journal-title":"Respiratory care"},{"issue":"14","key":"4671_CR4","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1042\/CS20181009","volume":"133","author":"B Atto","year":"2019","unstructured":"Atto, B., et al. (2019). New therapeutic targets for the prevention of infectious acute exacerbations of COPD: Role of epithelial adhesion molecules and inflammatory pathways. Clinical Science, 133(14), 1663\u20131703.","journal-title":"Clinical Science"},{"issue":"7","key":"4671_CR5","doi-asserted-by":"publisher","first-page":"3514","DOI":"10.1111\/jcmm.13628","volume":"22","author":"W Cui","year":"2018","unstructured":"Cui, W., et al. (2018). Nrf2 attenuates inflammatory response in COPD\/emphysema: Crosstalk with Wnt3a\/\u03b2-catenin and AMPK pathways. Journal of Cellular and Molecular Medicine, 22(7), 3514\u20133525.","journal-title":"Journal of Cellular and Molecular Medicine"},{"key":"4671_CR6","doi-asserted-by":"crossref","unstructured":"Yang, Y., et al., (2020). Advances in pharmacological actions and mechanisms of flavonoids from traditional Chinese medicine in treating chronic obstructive pulmonary disease. Evidence-Based Complementary and Alternative Medicine, 2020.","DOI":"10.1155\/2020\/8871105"},{"key":"4671_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejpb.2019.01.002","volume":"136","author":"A Mohamed","year":"2019","unstructured":"Mohamed, A., et al. (2019). Polymeric nanoparticles for the delivery of miRNA to treat chronic obstructive pulmonary disease (COPD). European Journal of Pharmaceutics and Biopharmaceutics, 136, 1\u20138.","journal-title":"European Journal of Pharmaceutics and Biopharmaceutics"},{"issue":"4","key":"4671_CR8","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.arbr.2019.09.011","volume":"56","author":"VJ Asensio","year":"2020","unstructured":"Asensio, V. J., et al. (2020). Eosinophilic COPD patients display a distinctive serum miRNA profile from asthma and non-eosinophilic COPD. Archivos de Bronconeumolog\u00eda (English Edition), 56(4), 234\u2013241.","journal-title":"Archivos de Bronconeumolog\u00eda (English Edition)"},{"key":"4671_CR9","doi-asserted-by":"publisher","first-page":"137081","DOI":"10.1016\/j.scitotenv.2020.137081","volume":"717","author":"J Chen","year":"2020","unstructured":"Chen, J., et al. (2020). Whole transcriptome-based miRNA-mRNA network analysis revealed the mechanism of inflammation-immunosuppressive damage caused by cadmium in common carp spleens. Science of The Total Environment, 717, 137081.","journal-title":"Science of The Total Environment"},{"key":"4671_CR10","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.2147\/COPD.S325300","volume":"16","author":"J An","year":"2021","unstructured":"An, J., et al. (2021). Identifying miRNA modules and related pathways of chronic obstructive pulmonary disease associated emphysema by weighted gene co-expression network analysis. International journal of chronic obstructive pulmonary disease, 16, 3119.","journal-title":"International journal of chronic obstructive pulmonary disease"},{"issue":"1","key":"4671_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.20473\/bhsj.v4i1.24432","volume":"4","author":"R Kuatama","year":"2021","unstructured":"Kuatama, R., Jusni, L. F. J., & Karina, C. (2021). A review of miRNAs accuracy as a diagnostic biomarker in COPD patients. Biomolecular and Health Science Journal, 4(1), 61\u201365.","journal-title":"Biomolecular and Health Science Journal"},{"issue":"32","key":"4671_CR12","doi-asserted-by":"publisher","first-page":"14229","DOI":"10.1073\/pnas.0913574107","volume":"107","author":"S Guo","year":"2010","unstructured":"Guo, S., et al. (2010). MicroRNA miR-125a controls hematopoietic stem cell number. Proceedings of the National Academy of Sciences, 107(32), 14229\u201314234.","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"1","key":"4671_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2407-10-318","volume":"10","author":"L Jiang","year":"2010","unstructured":"Jiang, L., et al. (2010). Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer, 10(1), 1\u201313.","journal-title":"BMC Cancer"},{"issue":"20","key":"4671_CR14","doi-asserted-by":"publisher","first-page":"7865","DOI":"10.1073\/pnas.1200081109","volume":"109","author":"S-W Kim","year":"2012","unstructured":"Kim, S.-W., et al. (2012). MicroRNAs miR-125a and miR-125b constitutively activate the NF-\u03baB pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20). Proceedings of the National Academy of Sciences, 109(20), 7865\u20137870.","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"4671_CR15","doi-asserted-by":"crossref","unstructured":"Hu, H.-L., et al., (2017). Circulating miR-125b but not miR-125a correlates with acute exacerbations of chronic obstructive pulmonary disease and the expressions of inflammatory cytokines. Medicine, 96(51).","DOI":"10.1097\/MD.0000000000009059"},{"key":"4671_CR16","unstructured":"\u674e\u5029, et al., (2023). \u4e2d\u836f\u9ec4\u82a9\u6291\u83cc\u4f5c\u7528\u7814\u7a76\u8fdb\u5c55. \u897f\u90e8\u4e2d\u533b\u836f, 36(02): 137\u2013140."},{"issue":"5A","key":"4671_CR17","first-page":"2861","volume":"20","author":"D-E Shieh","year":"2000","unstructured":"Shieh, D.-E., Liu, L.-T., & Lin, C.-C. (2000). Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer research, 20(5A), 2861\u20132865.","journal-title":"Anticancer research"},{"issue":"2","key":"4671_CR18","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s13318-018-0509-3","volume":"44","author":"T Huang","year":"2019","unstructured":"Huang, T., Liu, Y., & Zhang, C. (2019). Pharmacokinetics and bioavailability enhancement of baicalin: A review. European Journal of Drug Metabolism and Pharmacokinetics, 44(2), 159\u2013168.","journal-title":"European Journal of Drug Metabolism and Pharmacokinetics"},{"issue":"1","key":"4671_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s43440-019-00024-x","volume":"72","author":"P Fang","year":"2020","unstructured":"Fang, P., et al. (2020). Baicalin and its aglycone: A novel approach for treatment of metabolic disorders. Pharmacological Reports, 72(1), 13\u201323.","journal-title":"Pharmacological Reports"},{"issue":"5","key":"4671_CR20","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.pupt.2010.05.004","volume":"23","author":"Z Lixuan","year":"2010","unstructured":"Lixuan, Z., et al. (2010). Baicalin attenuates inflammation by inhibiting NF-\u03baB activation in cigarette smoke induced inflammatory models. Pulmonary pharmacology & therapeutics, 23(5), 411\u2013419.","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"4671_CR21","doi-asserted-by":"crossref","unstructured":"Wang, G., et al., (2018). Baicalin exerts anti-airway inflammation and anti-remodelling effects in severe stage rat model of chronic obstructive pulmonary disease. Evidence-Based Complementary and Alternative Medicine, 2018.","DOI":"10.1155\/2018\/7591348"},{"issue":"1","key":"4671_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s10020-021-00309-z","volume":"27","author":"D Hao","year":"2021","unstructured":"Hao, D., et al. (2021). Baicalin alleviates chronic obstructive pulmonary disease through regulation of HSP72-mediated JNK pathway. Molecular Medicine, 27(1), 53.","journal-title":"Molecular Medicine"},{"key":"4671_CR23","doi-asserted-by":"publisher","first-page":"102061","DOI":"10.1016\/j.pupt.2021.102061","volume":"70","author":"H Zhang","year":"2021","unstructured":"Zhang, H., et al. (2021). Baicalin ameliorates cigarette smoke-induced airway inflammation in rats by modulating HDAC2\/NF-\u03baB\/PAI-1 signalling. Pulmonary Pharmacology & Therapeutics, 70, 102061.","journal-title":"Pulmonary Pharmacology & Therapeutics"},{"issue":"5","key":"4671_CR24","doi-asserted-by":"publisher","first-page":"398S","DOI":"10.1378\/chest.117.5_suppl_2.398S","volume":"117","author":"R Rodriguez-Roisin","year":"2000","unstructured":"Rodriguez-Roisin, R. (2000). Toward a consensus definition for COPD exacerbations. Chest, 117(5), 398S-401S.","journal-title":"Chest"},{"issue":"5","key":"4671_CR25","doi-asserted-by":"publisher","first-page":"121S","DOI":"10.1378\/chest.121.5_suppl.121S","volume":"121","author":"DM Mannino","year":"2002","unstructured":"Mannino, D. M. (2002). COPD: Epidemiology, prevalence, morbidity and mortality, and disease heterogeneity. Chest, 121(5), 121S-126S.","journal-title":"Chest"},{"key":"4671_CR26","doi-asserted-by":"crossref","unstructured":"Bartal, M., (2005). COPD and tobacco smoke. Monaldi archives for chest disease. 63(4).","DOI":"10.4081\/monaldi.2005.623"},{"issue":"5","key":"4671_CR27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.pupt.2010.04.003","volume":"23","author":"JD Taylor","year":"2010","unstructured":"Taylor, J. D. (2010). COPD and the response of the lung to tobacco smoke exposure. Pulmonary pharmacology & therapeutics, 23(5), 376\u2013383.","journal-title":"Pulmonary pharmacology & therapeutics"},{"key":"4671_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3389\/fphys.2013.00091","volume":"4","author":"M Leberl","year":"2013","unstructured":"Leberl, M., Kratzer, A., & Taraseviciene-Stewart, L. (2013). Tobacco smoke induced COPD\/emphysema in the animal model\u2014are we all on the same page? Frontiers in physiology, 4, 91.","journal-title":"Frontiers in physiology"},{"issue":"3","key":"4671_CR29","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1183\/09031936.00206112","volume":"43","author":"PG Camp","year":"2014","unstructured":"Camp, P. G., et al. (2014). COPD phenotypes in biomass smoke-versus tobacco smoke-exposed Mexican women. European Respiratory Journal, 43(3), 725\u2013734.","journal-title":"European Respiratory Journal"},{"issue":"1","key":"4671_CR30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12931-017-0698-3","volume":"19","author":"J Olloquequi","year":"2018","unstructured":"Olloquequi, J., et al. (2018). Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both. Respiratory research, 19(1), 1\u20138.","journal-title":"Respiratory research"},{"issue":"3","key":"4671_CR31","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s13273-017-0027-4","volume":"13","author":"WJ Kim","year":"2017","unstructured":"Kim, W. J., & Lee, C. Y. (2017). Environmental exposures and chronic obstructive pulmonary disease. Molecular & Cellular Toxicology, 13(3), 251\u2013255.","journal-title":"Molecular & Cellular Toxicology"},{"issue":"5","key":"4671_CR32","first-page":"1477","volume":"40","author":"Y Hashiguchi","year":"2012","unstructured":"Hashiguchi, Y., et al. (2012). Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. International journal of oncology, 40(5), 1477\u20131482.","journal-title":"International journal of oncology"},{"key":"4671_CR33","doi-asserted-by":"publisher","first-page":"9317402","DOI":"10.1155\/2022\/9317402","volume":"2022","author":"W Sheng","year":"2022","unstructured":"Sheng, W., et al. (2022). Curcumol inhibits the development of prostate cancer by miR-125a\/STAT3 Axis. Evid Based Complement Alternat Med, 2022, 9317402.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"7","key":"4671_CR34","doi-asserted-by":"publisher","first-page":"6325","DOI":"10.1007\/s11033-022-07440-y","volume":"49","author":"F Ahmadpour","year":"2022","unstructured":"Ahmadpour, F., et al. (2022). Methylation-mediated silencing of miR-125a-5p facilitates breast cancer progression by inducing autophagy. Molecular Biology Reports, 49(7), 6325\u20136339.","journal-title":"Molecular Biology Reports"},{"key":"4671_CR35","doi-asserted-by":"publisher","first-page":"4098271","DOI":"10.1155\/2022\/4098271","volume":"2022","author":"Y Tong","year":"2022","unstructured":"Tong, Y., et al. (2022). LncRNA TP73-AS1 exacerbates the non-small-cell lung cancer (NSCLC) process via regulating miR-125a-3p-mediated ACTN4. Evid Based Complement Alternat Med, 2022, 4098271.","journal-title":"Evid Based Complement Alternat Med"},{"issue":"4","key":"4671_CR36","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.bbrc.2019.10.178","volume":"521","author":"J Zhu","year":"2020","unstructured":"Zhu, J., Wang, W., & Wu, X. (2020). Isorhynchophylline exerts anti-asthma effects in mice by inhibiting the proliferation of airway smooth muscle cells: The involvement of miR-200a-mediated FOXC1\/NF-\u03baB pathway. Biochemical and Biophysical Research Communications, 521(4), 1055\u20131060.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"4671_CR37","doi-asserted-by":"publisher","first-page":"105387","DOI":"10.1016\/j.phrs.2020.105387","volume":"164","author":"S Singh","year":"2021","unstructured":"Singh, S., Meena, A., & Luqman, S. (2021). Baicalin mediated regulation of key signaling pathways in cancer. Pharmacological Research, 164, 105387.","journal-title":"Pharmacological Research"},{"key":"4671_CR38","doi-asserted-by":"publisher","first-page":"7591348","DOI":"10.1155\/2018\/7591348","volume":"2018","author":"G Wang","year":"2018","unstructured":"Wang, G., et al. (2018). Baicalin exerts anti-airway inflammation and anti-remodelling effects in severe stage rat model of chronic obstructive pulmonary disease. Evid Based Complement Alternat Med, 2018, 7591348.","journal-title":"Evid Based Complement Alternat Med"},{"key":"4671_CR39","unstructured":"Hu, L.A.-O., et al. Baicalin inhibits airway smooth muscle cells proliferation through the RAS signaling pathway in murine asthmatic airway remodeling model,\u00a0Electronic\u00a0(pp. 1942\u20130994)."}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-023-04671-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-023-04671-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,11]],"date-time":"2024-06-11T16:06:21Z","timestamp":1718121981000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-023-04671-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,1]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["4671"],"URL":"https:\/\/doi.org\/10.1007\/s12010-023-04671-y","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,1]]},"assertion":[{"value":"16 August 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"It is not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"It is not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}